These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
554 related articles for article (PubMed ID: 27448560)
1. Top-down Proteomics: Technology Advancements and Applications to Heart Diseases. Cai W; Tucholski TM; Gregorich ZR; Ge Y Expert Rev Proteomics; 2016 Aug; 13(8):717-30. PubMed ID: 27448560 [TBL] [Abstract][Full Text] [Related]
2. Top-down proteomics: challenges, innovations, and applications in basic and clinical research. Brown KA; Melby JA; Roberts DS; Ge Y Expert Rev Proteomics; 2020 Oct; 17(10):719-733. PubMed ID: 33232185 [No Abstract] [Full Text] [Related]
3. Novel Strategies to Address the Challenges in Top-Down Proteomics. Melby JA; Roberts DS; Larson EJ; Brown KA; Bayne EF; Jin S; Ge Y J Am Soc Mass Spectrom; 2021 Jun; 32(6):1278-1294. PubMed ID: 33983025 [TBL] [Abstract][Full Text] [Related]
4. Top Down Proteomics Reveals Mature Proteoforms Expressed in Subcellular Fractions of the Echinococcus granulosus Preadult Stage. Lorenzatto KR; Kim K; Ntai I; Paludo GP; Camargo de Lima J; Thomas PM; Kelleher NL; Ferreira HB J Proteome Res; 2015 Nov; 14(11):4805-14. PubMed ID: 26465659 [TBL] [Abstract][Full Text] [Related]
5. MASH Suite Pro: A Comprehensive Software Tool for Top-Down Proteomics. Cai W; Guner H; Gregorich ZR; Chen AJ; Ayaz-Guner S; Peng Y; Valeja SG; Liu X; Ge Y Mol Cell Proteomics; 2016 Feb; 15(2):703-14. PubMed ID: 26598644 [TBL] [Abstract][Full Text] [Related]
6. Analysis of cardiac troponin proteoforms by top-down mass spectrometry. Tiambeng TN; Tucholski T; Wu Z; Zhu Y; Mitchell SD; Roberts DS; Jin Y; Ge Y Methods Enzymol; 2019; 626():347-374. PubMed ID: 31606082 [TBL] [Abstract][Full Text] [Related]
7. Temperature-sensitive sarcomeric protein post-translational modifications revealed by top-down proteomics. Cai W; Hite ZL; Lyu B; Wu Z; Lin Z; Gregorich ZR; Messer AE; McIlwain SJ; Marston SB; Kohmoto T; Ge Y J Mol Cell Cardiol; 2018 Sep; 122():11-22. PubMed ID: 30048711 [TBL] [Abstract][Full Text] [Related]
8. Top-down proteomics in health and disease: challenges and opportunities. Gregorich ZR; Ge Y Proteomics; 2014 May; 14(10):1195-210. PubMed ID: 24723472 [TBL] [Abstract][Full Text] [Related]
9. Top-Down Proteomics Applied to Human Cerebrospinal Fluid. Gay M; Sánchez-Jiménez E; Villarreal L; Vilanova M; Huguet R; Arauz-Garofalo G; Díaz-Lobo M; López-Ferrer D; Vilaseca M Methods Mol Biol; 2019; 2044():193-219. PubMed ID: 31432414 [TBL] [Abstract][Full Text] [Related]
10. Characterizing disease-associated changes in post-translational modifications by mass spectrometry. Thygesen C; Boll I; Finsen B; Modzel M; Larsen MR Expert Rev Proteomics; 2018 Mar; 15(3):245-258. PubMed ID: 29376447 [TBL] [Abstract][Full Text] [Related]
11. Simultaneous Quantification of Protein Expression and Modifications by Top-down Targeted Proteomics: A Case of the Sarcomeric Subproteome. Lin Z; Wei L; Cai W; Zhu Y; Tucholski T; Mitchell SD; Guo W; Ford SP; Diffee GM; Ge Y Mol Cell Proteomics; 2019 Mar; 18(3):594-605. PubMed ID: 30591534 [TBL] [Abstract][Full Text] [Related]
12. Defining the Sarcomeric Proteoform Landscape in Ischemic Cardiomyopathy by Top-Down Proteomics. Chapman EA; Aballo TJ; Melby JA; Zhou T; Price SJ; Rossler KJ; Lei I; Tang PC; Ge Y J Proteome Res; 2023 Mar; 22(3):931-941. PubMed ID: 36800490 [TBL] [Abstract][Full Text] [Related]
13. Proteomics of the heart: unraveling disease. McGregor E; Dunn MJ Circ Res; 2006 Feb; 98(3):309-21. PubMed ID: 16484627 [TBL] [Abstract][Full Text] [Related]
14. Profiling of Histone Post-Translational Modifications in Mouse Brain with High-Resolution Top-Down Mass Spectrometry. Zhou M; Paša-Tolić L; Stenoien DL J Proteome Res; 2017 Feb; 16(2):599-608. PubMed ID: 28001079 [TBL] [Abstract][Full Text] [Related]
15. Post-translational quantitation by SRM/MRM: applications in cardiology. Gianazza E; Banfi C Expert Rev Proteomics; 2018 Jun; 15(6):477-502. PubMed ID: 29865883 [TBL] [Abstract][Full Text] [Related]
16. Proteomics in heart failure: top-down or bottom-up? Gregorich ZR; Chang YH; Ge Y Pflugers Arch; 2014 Jun; 466(6):1199-209. PubMed ID: 24619480 [TBL] [Abstract][Full Text] [Related]
17. Identification, Quantification, and Site Localization of Protein Posttranslational Modifications via Mass Spectrometry-Based Proteomics. Ke M; Shen H; Wang L; Luo S; Lin L; Yang J; Tian R Adv Exp Med Biol; 2016; 919():345-382. PubMed ID: 27975226 [TBL] [Abstract][Full Text] [Related]
18. Top-down quantitative proteomics identified phosphorylation of cardiac troponin I as a candidate biomarker for chronic heart failure. Zhang J; Guy MJ; Norman HS; Chen YC; Xu Q; Dong X; Guner H; Wang S; Kohmoto T; Young KH; Moss RL; Ge Y J Proteome Res; 2011 Sep; 10(9):4054-65. PubMed ID: 21751783 [TBL] [Abstract][Full Text] [Related]
19. Top-down targeted proteomics for deep sequencing of tropomyosin isoforms. Peng Y; Chen X; Zhang H; Xu Q; Hacker TA; Ge Y J Proteome Res; 2013 Jan; 12(1):187-98. PubMed ID: 23256820 [TBL] [Abstract][Full Text] [Related]